HappeningToo topic
Certolizumab Pegol reports
Browse community reports connected to Certolizumab Pegol. These reports can show that other people are describing similar experiences, but they do not prove that Certolizumab Pegol caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
23 problems
Abdominal Discomfort while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and abdominal discomfort appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and abdominal pain upper appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and abdominal pain appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and alopecia appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and decreased appetite appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and diarrhea appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and dizziness appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and fatigue appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and headache appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and hives appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and insomnia appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and itching appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and malaise appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and nausea appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and pain appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and rash appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and shortness of breath appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and sleep disorder appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and swelling appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and vomiting appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and weakness appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and weight decreased appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Certolizumab Pegol
FDA FAERS contains adverse-event reports in which Certolizumab Pegol and weight increased appear together. This does not establish that Certolizumab Pegol caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →